APP and Alzheimer disease: Recent work from Freude et al. (Freude et al., 2009) showed that IRS2 deficiency in the Tg2576 AD mouse model reduced both the β cleavage of APP and the levels of Aβ in the brain and was able to reverse the premature mortality of the Tg2576 single-transgenics.